Literature DB >> 2859163

Drug metabolism by isolated fetal human hepatocytes in suspension and primary culture.

P Wiebkin, J H Dees, J M Mathis, R A Prough.   

Abstract

Isolated viable hepatocytes of human fetuses (weeks 12-34 of gestation) were prepared by collagenase/hyaluronidase digestion of liver slices. These cells have the ability to catalyze certain metabolic transformations involved in the disposition of xenobiotics. The levels of enzymes catalyzing oxidative metabolism (phase I) were very low in the fetal liver cells, although such cells possess appreciable metabolic capacity to catalyze synthetic (phase II) reactions. These cells retained the ability to metabolize 7-ethoxycoumarin when maintained in short term, nonproliferating monolayer culture for up to 4 days. The metabolism of 7-ethoxycoumarin was significantly increased by treatment of cells with 1,2-benzanthracene, but not with phenobarbital. The usefulness of isolated fetal human hepatocytes both in suspension and short term culture as model systems for the study of developmental aspects of the enzymes involved in the metabolism of foreign compounds and as a tool for study of various toxic effects of chemicals on the human fetus is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859163

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  2 in total

1.  Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes.

Authors:  Shringi Sharma; Ewa C S Ellis; Kenneth Dorko; Shimin Zhang; Donald R Mattison; Steve N Caritis; Raman Venkataramanan; Stephen C Strom
Journal:  Drug Metab Dispos       Date:  2010-01-22       Impact factor: 3.922

2.  Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes.

Authors:  Shringi Sharma; Ewa C S Ellis; Roberto Gramignoli; Kenneth Dorko; Veysel Tahan; Marc Hansel; Donald R Mattison; Steve N Caritis; Ronald N Hines; Raman Venkataramanan; Stephen C Strom
Journal:  Drug Metab Dispos       Date:  2012-11-05       Impact factor: 3.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.